コンテンツへスキップ
· バイオリバイタライゼーション
SKU 11210

Viscoderm 0.8

In stock
Volume
3 x 1 mL
Laboratory
IBSA
Origin
イタリア
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Viscoderm 0.8 is a sterile, single-use injectable hyaluronic acid medical device by IBSA, indicated to counteract slight xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified personnel. Its highly purified sodium hyaluronate is obtained by fermentation, is not chemically modified and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. Each 1 ml pre-filled syringe contains 8 mg of it.

主なメリット: Viscoderm 0.8

  • Highly purified hyaluronic acid obtained by fermentation
  • Not chemically modified
  • Molecular weight of approximately 1 million Dalton
  • Supports restoration of physiological hyaluronic acid levels in treated tissue
  • Supports tissue rehydration
  • Helps create favourable conditions for tissue remodelling
  • Indicated for slight xerodermia associated with dermatitis and/or psoriasis
  • High biocompatibility and excellent tolerability
  • Sterile, pyrogen-free and single-use
主な情報
ブランド Viscoderm
製造元 IBSA
原産国 Italy
認証 CE-marked medical device for intradermal use, CE 0477
成分 Per 1 ml syringe: sodium hyaluronate 8.000 mg; sodium chloride 8.500 mg; sodium phosphate 0.205 mg; water for injection q.s. 1.0 ml
容量 / サイズ 1 ml per syringe, 3 ml per pack
包装 3 pre-filled syringes x 1 ml, with 6 needles 30G x 1/2 inch (0.3 x 12 mm)
針のサイズ 30G x 1/2 inch (0.3 x 12 mm), 6 needles supplied per pack
使用タイプ Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.
注入の深さ Intradermal, at medium-deep level, using a linear or picotage technique
プロトコル / 期間 Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

適応と専門的な使用

主な適応

  • Slight xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

専門的な使用

Viscoderm 0.8 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

施術部位

  • Intradermal administration, at medium-deep level
  • The treating practitioner determines the area treated

対象となる患者

Viscoderm 0.8 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 0.8% concentration is indicated to counteract slight xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

作用の仕組み: Viscoderm 0.8 ​

Viscoderm 0.8 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 0.8% concentration is the lowest of the three in the range and is the one indicated for slight xerodermia.

Allparaで注文する理由

Allparaは、正規品で検証済みの VISCODERM 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

その他の製品: IBSA

View laboratory

VISCODERM references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.

View VISCODERM products

VISCODERM Products

View all 10

PROFHILO references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.

View PROFHILO products

PROFHILO Products

View all 8
Profhilo H+L
Profhilo H+L バイオリバイタライゼーション
Profhilo Structura
Profhilo Structura バイオリバイタライゼーション
Profhilo Body
Profhilo Body バイオリバイタライゼーション
Profhilo Body Kit
Profhilo Body Kit バイオリバイタライゼーション

Clinic alternatives

All products

Viscoderm 0.8

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Viscoderm 0.8 is a sterile, single-use injectable hyaluronic acid medical device by IBSA, indicated to counteract slight xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified personnel. Its highly purified sodium hyaluronate is obtained by fermentation, is not chemically modified and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. Each 1 ml pre-filled syringe contains 8 mg of it.

主なメリット: Viscoderm 0.8

  • Highly purified hyaluronic acid obtained by fermentation
  • Not chemically modified
  • Molecular weight of approximately 1 million Dalton
  • Supports restoration of physiological hyaluronic acid levels in treated tissue
  • Supports tissue rehydration
  • Helps create favourable conditions for tissue remodelling
  • Indicated for slight xerodermia associated with dermatitis and/or psoriasis
  • High biocompatibility and excellent tolerability
  • Sterile, pyrogen-free and single-use
主な情報
ブランド Viscoderm
製造元 IBSA
原産国 Italy
認証 CE-marked medical device for intradermal use, CE 0477
成分 Per 1 ml syringe: sodium hyaluronate 8.000 mg; sodium chloride 8.500 mg; sodium phosphate 0.205 mg; water for injection q.s. 1.0 ml
容量 / サイズ 1 ml per syringe, 3 ml per pack
包装 3 pre-filled syringes x 1 ml, with 6 needles 30G x 1/2 inch (0.3 x 12 mm)
針のサイズ 30G x 1/2 inch (0.3 x 12 mm), 6 needles supplied per pack
使用タイプ Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.
注入の深さ Intradermal, at medium-deep level, using a linear or picotage technique
プロトコル / 期間 Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

適応と専門的な使用

主な適応

  • Slight xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

専門的な使用

Viscoderm 0.8 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

施術部位

  • Intradermal administration, at medium-deep level
  • The treating practitioner determines the area treated

対象となる患者

Viscoderm 0.8 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 0.8% concentration is indicated to counteract slight xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

作用の仕組み: Viscoderm 0.8 ​

Viscoderm 0.8 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 0.8% concentration is the lowest of the three in the range and is the one indicated for slight xerodermia.

Allparaで注文する理由

Allparaは、正規品で検証済みの VISCODERM 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。

よくある質問

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

その他の製品: IBSA

ラボを見る →
* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.